基于“肝主疏泄”理论探讨脂肪肝分期治疗
|
摘要
肝主疏泄理论在中医认识疾病的过程中起着重要的指导作用,其中调节气血津液代谢功能尤为重要。肝疏泄有度则气血津液运行正常,肝失疏泄则气滞湿阻血瘀,百病由生。脂肪肝发病表现为气血津液代谢障碍,符合肝失疏泄的特点,气滞、痰湿、血瘀分别在脂肪肝不同阶段发病中起着关键的作用,故其治疗当纠正肝失疏泄,根据所处阶段的病机特点而分别重视疏肝理气、祛湿化痰、活血化瘀之法。
The theory of liver controlling conveyance and dispersion plays an important guiding role in the process of TCM understanding of diseases,among which regulating the metabolism of qi,blood and fluid is particularly important.The liver's normal function means normal circulation of qi blood and body fluid,otherwise it brings us qi stagnation,fluid resistance and blood stasis,followed by diseases.Fatty liver is a modern medical name and appears as the metabolic disorder of qi blood and body fluid,meeting the characteristics of not liver freely distributing,qi stagnation,fluid resistance or blood stasis plays an important role in different stages.Therefore,the treatment of fatty liver disease needs correction of liver dysfunction.In order to get the metabolism of qi blood and body fluid recovery,soothing liver regulating qi,eliminating dampness and phlegm,promoting blood circulation and removing blood stasis are supposed to be applied for pathogenesis characteristics at different stages of the disease.
The theory of liver controlling conveyance and dispersion plays an important guiding role in the process of TCM understanding of diseases,among which regulating the metabolism of qi,blood and fluid is particularly important.The liver's normal function means normal circulation of qi blood and body fluid,otherwise it brings us qi stagnation,fluid resistance and blood stasis,followed by diseases.Fatty liver is a modern medical name and appears as the metabolic disorder of qi blood and body fluid,meeting the characteristics of not liver freely distributing,qi stagnation,fluid resistance or blood stasis plays an important role in different stages.Therefore,the treatment of fatty liver disease needs correction of liver dysfunction.In order to get the metabolism of qi blood and body fluid recovery,soothing liver regulating qi,eliminating dampness and phlegm,promoting blood circulation and removing blood stasis are supposed to be applied for pathogenesis characteristics at different stages of the disease.
引文
[1]范建高.非酒精性脂肪肝的临床流行病学研究[J].中华消化杂志,2002,22(2):106-107.
[2]陈灏珠.实用内科学[M].北京:人民卫生出版社,2009:2101.
[3]何勇.分期辨证治疗非酒精性脂肪肝[J].中医文献杂志,2009(4):36-37.
[4]刘艳骄,王琦.历代医家对肥胖人痰湿体质的认识[J].山东中医学院学报,1992,16(6):43-45.
[5]谢纪文,李宏春,杨胜兰,等.非酒精性脂肪肝血瘀证患者血液流变学变化[J].中国中西医结合消化杂志,2004,12(5):284-285.
[6]王峰.柴胡疏肝散合二陈汤加减治疗脂肪性肝炎[J].交通医学,2008,22(1):48.
[7]司金超,杜建海,李伟,等.香附对大鼠离体脂肪组织释放游离脂肪酸的影响[J].中药药理与临床,2002,18(5):30-32.
[8]吴尤娇,黄敏桃,黄云峰,等.毛郁金乙醇提取物降血脂作用研究[J].广西科学,2015,22(2):130-134.
[9]陈振鹤,吴国泰,任远.枳壳的化学成分·药理作用及临床应用[J].安徽农业科学,2016,44(26):95-97.
[10]姜淋洁,付涛,卢锟刚,等.白术提取物对大鼠预防性调血脂及保肝作用的实验研究[J].数理医药学杂志,2011,24(4):398-401.
[11]王焱,李俊,王保伟.橙皮苷对非酒精性脂肪肝大鼠的保护作用及其机制的初探[J].安徽医科大学学报,2010,45(3):646-650.
[12]游昕,熊大国,郭志斌,等.茯苓多种化学成分及药理作用的研究进展[J].安徽农业科学,2015,43(2):106-109.
[13]张翠英,章洪,戚琼华.川芎的有效成分及药理研究进展[J].辽宁中医杂志,2014,41(10):2264-2266.
[14]辛淑杰.丹参的药理作用及临床应用探讨[J].中国民族民间医药,2013(5):26-27.
[15]张巍.赤芍对肝纤维化因子ECM等的影响[J].临床合理用药杂志,2011,4(5):74-75.
[16]覃星柳,杨萍.丹皮酚对大鼠肝纤维化治疗作用的实验研究[J].河北中医,2015,37(4):546-549.
[2]陈灏珠.实用内科学[M].北京:人民卫生出版社,2009:2101.
[3]何勇.分期辨证治疗非酒精性脂肪肝[J].中医文献杂志,2009(4):36-37.
[4]刘艳骄,王琦.历代医家对肥胖人痰湿体质的认识[J].山东中医学院学报,1992,16(6):43-45.
[5]谢纪文,李宏春,杨胜兰,等.非酒精性脂肪肝血瘀证患者血液流变学变化[J].中国中西医结合消化杂志,2004,12(5):284-285.
[6]王峰.柴胡疏肝散合二陈汤加减治疗脂肪性肝炎[J].交通医学,2008,22(1):48.
[7]司金超,杜建海,李伟,等.香附对大鼠离体脂肪组织释放游离脂肪酸的影响[J].中药药理与临床,2002,18(5):30-32.
[8]吴尤娇,黄敏桃,黄云峰,等.毛郁金乙醇提取物降血脂作用研究[J].广西科学,2015,22(2):130-134.
[9]陈振鹤,吴国泰,任远.枳壳的化学成分·药理作用及临床应用[J].安徽农业科学,2016,44(26):95-97.
[10]姜淋洁,付涛,卢锟刚,等.白术提取物对大鼠预防性调血脂及保肝作用的实验研究[J].数理医药学杂志,2011,24(4):398-401.
[11]王焱,李俊,王保伟.橙皮苷对非酒精性脂肪肝大鼠的保护作用及其机制的初探[J].安徽医科大学学报,2010,45(3):646-650.
[12]游昕,熊大国,郭志斌,等.茯苓多种化学成分及药理作用的研究进展[J].安徽农业科学,2015,43(2):106-109.
[13]张翠英,章洪,戚琼华.川芎的有效成分及药理研究进展[J].辽宁中医杂志,2014,41(10):2264-2266.
[14]辛淑杰.丹参的药理作用及临床应用探讨[J].中国民族民间医药,2013(5):26-27.
[15]张巍.赤芍对肝纤维化因子ECM等的影响[J].临床合理用药杂志,2011,4(5):74-75.
[16]覃星柳,杨萍.丹皮酚对大鼠肝纤维化治疗作用的实验研究[J].河北中医,2015,37(4):546-549.